Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

IMPL

Impel Pharmaceuticals (IMPL)

Impel Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IMPL
DateTimeSourceHeadlineSymbolCompany
08/16/20218:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMPLImpel Pharmaceuticals Inc
08/09/20214:01PMGlobeNewswire Inc.Impel NeuroPharma to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021NASDAQ:IMPLImpel Pharmaceuticals Inc
08/09/20218:00AMGlobeNewswire Inc.Impel NeuroPharma Announces Publication of Pivotal Phase 3, Open-Label Stop 301 Study of INP104 (TRUDHESAâ„¢) for Treatment of Acute Migraine in the Journal HeadacheNASDAQ:IMPLImpel Pharmaceuticals Inc
08/03/20214:01PMGlobeNewswire Inc.Impel NeuroPharma to Present at the 2021 Wedbush Pacgrow Virtual Healthcare ConferenceNASDAQ:IMPLImpel Pharmaceuticals Inc
07/29/20218:00AMGlobeNewswire Inc.Impel NeuroPharma to Host Virtual Key Opinion Leader Event on August 6, 2021NASDAQ:IMPLImpel Pharmaceuticals Inc
07/26/20216:01PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
07/26/20215:59PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
07/26/20215:58PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
07/13/20215:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
07/13/20215:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
07/13/20215:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
07/13/20215:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMPLImpel Pharmaceuticals Inc
07/07/20218:05AMGlobeNewswire Inc.Impel NeuroPharma Enters Into a $50 Million Debt Financing Agreement With Oxford Finance LLC and Silicon Valley BankNASDAQ:IMPLImpel Pharmaceuticals Inc
07/07/20217:31AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMPLImpel Pharmaceuticals Inc
06/22/20215:42PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:IMPLImpel Pharmaceuticals Inc
06/16/20218:00AMGlobeNewswire Inc.Impel NeuroPharma to Present at the Raymond James Human Health Innovation ConferenceNASDAQ:IMPLImpel Pharmaceuticals Inc
06/07/20214:58PMEdgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:IMPLImpel Pharmaceuticals Inc
06/07/20218:05AMGlobeNewswire Inc.Impel NeuroPharma Announces First Quarter 2021 Financial Results and Provides Business UpdateNASDAQ:IMPLImpel Pharmaceuticals Inc
06/07/20218:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMPLImpel Pharmaceuticals Inc
06/07/20217:18AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:IMPLImpel Pharmaceuticals Inc
06/02/20218:00AMGlobeNewswire Inc.Impel Neuropharma to Present Pivotal, Phase 3 Data From STOP-301 Study at The 63rd Annual Meeting of the American Headache So...NASDAQ:IMPLImpel Pharmaceuticals Inc
05/18/20218:00AMGlobeNewswire Inc.Impel NeuroPharma Launches Reroute Migraine Relief, Educational Initiative That Brings to Life the Underrecognized Connection...NASDAQ:IMPLImpel Pharmaceuticals Inc
04/22/20216:48PMGlobeNewswire Inc.Impel NeuroPharma Announces Pricing of $80.0 Million Initial Public OfferingNASDAQ:IMPLImpel Pharmaceuticals Inc
04/28/20054:57PMPR Newswire (US)Nasdaq Approves Imperial Industries, Inc. for Small Cap Market Listing Under Trading Symbol 'IPII'NASDAQ:IMPL
03/30/20054:38PMPR Newswire (US)Imperial Announces 2004 ResultsNASDAQ:IMPL
03/22/200511:31AMPR Newswire (US)Imperial Industries, Inc. Reverse Split Delayed Until March 23, 2005 Under New Trading Symbol 'IMPL'NASDAQ:IMPL
 Showing the most relevant articles for your search:NASDAQ:IMPL